Rocket Lab Rides a Rare Twin Catalyst: Index Inclusion and SpaceX Debut Converge
12.06.2026 - 17:26:33 | boerse-global.de
Rocket Lab’s shares caught an unusual double tailwind on Friday, as the company’s pending entry into the Nasdaq-100 index coincided with the long-awaited initial public offering of SpaceX. The stock closed the regular session at €105.60, up 6.24% on the day, before surging nearly 11% in after-hours trading to $126.95. The weekly gain hit 10.58%, though the stock still sits roughly 21% below the 52-week high of €133.80 reached in late May.
Index inclusion is rarely this timely. Nasdaq confirmed on 11 June that Rocket Lab would join the Nasdaq-100, effective before the open on 22 June 2026 — making it the first New Zealand-founded company ever to enter the benchmark. The practical effect is immediate and mechanical: more than 200 exchange-traded funds and other investment products track the index, collectively managing over $800 billion in assets. All of those vehicles must now buy Rocket Lab shares to align their portfolios, generating a wave of structural demand independent of any analyst rating or price target.
The simultaneous SpaceX IPO only amplified the enthusiasm. The sector leader listed at $135 per share, giving it a valuation of roughly $1.77 trillion, and raised $75 billion in the process. The sheer scale of the debut pulled the entire space sector upward, with Rocket Lab benefiting as the best-known publicly traded alternative in orbital launch and satellite services. Management also sees a strategic opening as SpaceX increasingly focuses on its Starlink constellation and the massive Starship vehicle, leaving room for Rocket Lab’s medium-lift Neutron rocket.
Should investors sell immediately? Or is it worth buying Rocket Lab?
Operational momentum provides a solid foundation for the stock’s recent gains. Rocket Lab reported record first-quarter revenue of $200.3 million, a 63.5% year-over-year jump, with gross margin improving to 38.2%. The order backlog now stands at $2.2 billion, secured by more than 70 contracted missions. The company recently completed production of its 100th Electron rocket, while the first flight of the larger Neutron vehicle remains on track for the end of 2026, despite a test failure in February. The acquisition of Mynaric has also strengthened its position in laser-based satellite communications.
Analysts are split on valuation but acknowledge the improving backdrop. KGI Securities initiated coverage on 11 June with a “Neutral” rating and a price target of $105, roughly in line with current levels. Stifel Nicolaus maintains a more bullish view at $132. For the second quarter, Rocket Lab expects revenue between $225 million and $240 million, and adjusted EBITDA to remain negative at between minus $20 million and minus $26 million. With a rising launch cadence and expanding margins, the company is inching closer to operating profitability — and the forced buying from index trackers over the next week provides an extra lift that no analyst call can replicate.
Ad
Rocket Lab Stock: New Analysis - 12 June
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
